What We’re Reading: Flawed Racial Vaccine Data; Breast Cancer Pill Benefits; 2 Billion Global COVID-19 Shots
Eighteen months into the pandemic, states continue to report flawed racial and ethnic data on vaccine administration; promising study results have been seen for a breast cancer pill; 2 billion COVID-19 vaccines have been administered worldwide.
Gaps in Racial, Ethnic Vaccine Data Persist
With states being left to equitably distribute vaccines to their vulnerable citizens throughout the COVID-19 pandemic, gaps and inconsistencies in data have made these efforts difficult to track, Kaiser Health News
Breast Cancer Pill Demonstrates Early Promise
Early initial treatment findings show that Lynparza (olaparib) helps keep certain early-stage, triple-negative breast cancers at bay, according to
2 Billion Vaccine Doses Administered
Two billion COVID-19 vaccines throughout the world have now been administered, Bloomberg
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025
- Modest Reductions in PrEP Coverage Result in Avoidable HIV Infections
September 17th 2025